Market Outlook
The Global Human Metapneumovirus Diagnostics Market, valued at USD 564.22 million in 2024, is projected to reach USD 946.38 million by 2030, growing at a robust CAGR of 8.96% during the forecast period. This growth is fueled by the rising prevalence of respiratory infections caused by human metapneumovirus (hMPV), particularly in children, the elderly, and immunocompromised patients.
Advancements in diagnostic technologies, including PCR-based diagnostics and next-generation sequenc